A new lawsuit involving birth defects related to the popular and widely-used antidepressant Zoloft has been filed, adding to the multidistrict litigation case taking place in the Eastern District of Pennsylvania. Kathy Williams, the plaintiff, filed suit after her child was born with a number... Read More

A new lawsuit against Pradaxa manufacturer Boehringer Ingelheim Pharmaceuticals alleges that the company was aware of the risk of internal bleeding from Pradaxa, but failed to warn patients, the public, or the medical community. The lawsuit was filed by Thelma Hawthorne in the U.S. District... Read More

The manufacturer of the once-popular fourth generation birth control pill Yaz has been forced to pay out about $142 million in settlements to patients who have filed lawsuits after experiencing serious side effects as a result of their use of the birth control. Plaintiffs who... Read More

Pradaxa is a blood thinning medication that was introduced relatively recently as an alternative to older blood thinning drugs. However, a number of patients have experienced complications and side effects as a result of their use of the drug, and a number of them have... Read More

Federal lawsuits dealing with the DePuy Pinnacle hip replacement system and complications thereof were consolidated into a multidistrict litigation lawsuit in May of 2011. More than 1,600 cases are currently consolidated in the multidistrict litigation case, where they are pending. The MDL is located in... Read More

A growing number of plaintiffs are filing lawsuits against drug company Boehringer Ingelheim Pharmaceuticals charging that they suffered internal bleeding from Pradaxa, an anticoagulant medication. Pradaxa is used to prevent stroke in patients who suffer from non-valvular atrial fibrillation, a condition that allows blood clots... Read More

The Yaz multidistrict litigation in Illinois has gained another lawsuit. The new lawsuit against Bayer, manufacturer of Yaz and Yasmin, was filed on May 15, 2012 in the U.S. District Court for the Southern District of Illinois (East St. Louis), by Massachusetts resident Janet Mahon,... Read More

Pradaxa was introduced as an atrial fibrillation treatment in 2010 by the Food and Drug Administration, who approved the drug as an alternative to the previously used warfarin, known by its brand name Coumadin most commonly. Pradaxa is manufactured by drug maker Boehringer Ingelheim Pharmaceuticals.... Read More